Dual calcium-voltage optical mapping of regional voltage and calcium signals in intact murine RyR2-R2474S hearts Authors: Yangpeng Li, Zhu Liu, Christopher O'Shea, Jianhong Li, Xian Luo, Tangting Chen, Xianhong Ou, Weichao Liu, Guoliang Hao, Christopher L.-H. Huang, Davor Pavlovic, Xiaoqiu Tan, Ming Lei Published: 2024 ABSTRACT Abnormal regional variations in electrical and calcium homeostasis properties have been implicated in catecholaminergic polymorphic ventricular tachycardias (CPVT) attributable to abnormal RyR2-mediated store Ca2+ release, but their underlying mechanism have not been well explored in intact hearts.MethodsWe performed in vivo and ex vivo studies including high throughput mapping of Ca2+ transients (CaT) and transmembrane voltage (Vm) in murine wild-type (WT) and heterozygous RyR2-R2474S/+ hearts, before and during isoprenaline (ISO) challenge.ResultsISO-challenged RyR2-R2474S/+ showed increased incidence of arrhythmia accompanied by abnormal Ca2+ transients compared to WT. CaT duration (CaTD) in the LV apex amongst regions studied both before and during ISO challenge in both WT and RyR2-R2474S/+ ventricles. RyR2-R2474S/+ ventricles showed prolonged CaTD, both before and during isoprenaline (ISO) challenge. Conversely, action potential durations (APD) were the same in WT and RyR2-R2474S/+ ventricles and identically reduced by ISO challenge. RyR2-R2474S/+ showed Vm-CaT latencies at time to half decay, but not rise time to peak, which were significantly prolonged compared to WT in all ventricular regions examined with ISO challenge. Following burst pacing, ventricular localized concordant alternans in CaT and APD were readily observed in RyR2-R2474S/+ but not in WT mice. Such CaT and APD alternans occurred mostly semiannually in specific regions of the ventricular pre-occurrence of VT.ConclusionThe pro-arrhythmic RyR2-R2474S/+ phenotype in intact hearts thus directly parallels delayed regional CaT recovery properties and alteration of Vm-CaT latencies. Studies suggest that discordant localized calcium alternans are mechanistically responsible for action potential duration alternans and occurrence of VT in RyR2-R2474S/+ mice. Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare genetic arrhythmic syndrome, which can progress to potentially fatal ventricular fibrillation (VF) triggered by physical activity, stress and catecholamine challenge [[1], [2], [3], [4]]. Symptoms typically include recurrent syncope, seizures, or sudden death following exertion or emotional stress [5]. Previous research has identified several genes associated with CPVT and sarcoplasmic reticular (SR) Ca2+ release, including RYR2, FKBP12.6, CASQ2, TRDN, and CALM1-3[[6], [7], [8], [9], [10], [11], [12]]. The occurrence of cardiomyocyte cytosolic Ca2+ waves is more likely when background cytosolic [Ca2+] increases due to RyR sensitization by catecholaminergic challenge. The mechanisms by which defective RyR2 channels lead to ventricular arrhythmias in CPVT remain incompletely understood. For instance, cardiac alternans have been linked to ventricular arrhythmia in CPVT patients [13], with Ca2+ alternans believed to play a central role in their genesis. However, at the single-cell level, Ca2+ alternans can occur independently of action potential duration (APD) alternans. Wen et al. [14] demonstrated this dissociation by simultaneously recording membrane potential and Ca2+ transients in isolated cardiomyocytes, showing that Ca2+ alternans could occur without APD alternans, while APD alternans did not occur without Ca2+ alternans. A growing body of evidence supports the idea that Ca2+ dysregulation primarily contributes to cardiac alternans [15,16]. Over the past two decades, emerging evidence strongly suggests that the normal electrical function of the heart results from dynamic interactions between membrane ion channels and intracellular Ca2+ handling proteins within a complex molecular network [17,18]. Recently, a two-clock theory was proposed to explain normal and abnormal cardiac electrophysiological function [18]. According to this theory, a membrane (M) clock governs surface electrophysiological changes and excitation conduction, which in turn influences the calcium (C-) clock by modulating cytosolic Ca2+ levels. This triggers cycles of store Ca2+ release and re-uptake, primarily regulated by the M-clock's activation and recovery processes. However, the C-clock also influences the M-clock by altering action potential conduction, recovery, and post-recovery stability, as well as exerting longer-term effects on channel expression. Autonomic sympathetic and parasympathetic control mechanisms act at different control points within the C- and M-clocks, respectively. This novel clock theory holds promise for elucidating how dysfunction of specific membrane or Ca2+ handling proteins leads to cardiac arrhythmias, including CPVT. In the present study, we studied hearts from the wild type mice and mice with heterozygous R2474S mutation in RyR2 (RyR2-R2474S) that exhibit exercise-induced ventricular arrhythmias and sudden cardiac death, first reported by Lehnart et al. [19]. We conducted dual dye optical mapping of transmembrane voltage (Vm) and intracellular Ca2+ transients (CaT) in Langendorff perfused hearts, providing high-throughput characterization of action potentials (APs) and intracellular Ca2+ transients (CaT) and their relationship in hearts from WT and RyR2-R2474S mice under baseline and adrenergic stress conditions. We performed four series of detailed electrophysiological analyses in in vivo and intact hearts. Firstly, we assessed the arrhythmic incidence under basal and adrenergic stress conditions in wild-type control and RyR2R2474S/+ mice in vivo and ex vivo hearts. Then, we characterized the global and regional ventricular profiles of calcium transient properties and action potentials in WT and RyR2-R2474S hearts. This enabled us to determine how defective channels alter the calcium (C-) clock at the cellular level results in Ca2+ transients global and regional effects and determined whether such altered C-clock also results in an alteration of M-clock through alterations in AP depolarization or repolarization dynamics. Then we analyzed the conduction properties of Vm in Langendorff perfused hearts from WT and Ryr2-R2474S hearts, which allows us to understand how defective C-clock in mutant heart feeds back onto the M-clock, altering AP conduction. Finally, by analyzing voltage ‑calcium latency, we explored the C- and M-clock coupling and how defective RyR2-R2474S channels particular the Ca2+ alternans affect such coupling thus underlying arrhythmogenesis. Taken together, our study provides new insights into the arrhythmogenic mechanisms of CPVT at tissue level. Materials and methods Ethics and study approval All procedures were approved by the Institutional Animals Ethics Committee at Southwest Medical University, Luzhou, China under the national guidelines under which the institution operates, which conform with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. Wild type (WT) and RyR2-R2474S/+ knock-in mice were provided by the Experimental Animal Center of Southwest Medical University and maintained in its pathogen−free facility with ad libitum access to food and water. ECG monitoring Mice (male and female, 8–10 weeks) were anesthetized with 2–5 % isoflurane using a gas anaesthesia machine (RWD Life Science, Shenzhen City, Guangdong Province, China). ECG monitoring before and through the 30 min following isoprenaline (ISO) (1 or 10 mg/kg i.p.; Cat: HY-B0468; MedChem Express, USA) challenge in both RyR2-R2474S/+ (n = 8) and WT mice (n = 8) used the multi‑lead MP150 recording instrument (BIOPAC system, Inc. USA). Langendorff-perfused isolated hearts C57 mice (male and female, 8–10 weeks) were anesthetized as described above. Hearts were quickly excised and placed in Krebs solution (mM: 128 NaCl, 20 NaHCO3, 4 KCl, 1.2 NaH2PO4, 1.05 MgCl2, 1.35 CaCl2, and 10 d-glucose, equilibrated with 5 % CO2 and 95 % O2; pH titrated to 7.4), then mounted onto a Langendorff perfusion system and perfused with Krebs solution with a 2 mL/min flow rate at 37 °C. Hearts were perfused and monitored for stability for 10 min before commencing experimental procedures. Optical mapping of ex vivo cardiac preparations After the Langendorff-perfused hearts reached steady state, contraction artefacts were minimized using blebbistatin (10 μM). Dye loading was aided by pre-perfusion with pluronic F127 (20 % w/v in DMSO). RH237 (1 mg/mL, stock solution Cat: S1109, Thermo Fisher Scientific, USA) and Rhod2-AM (1 mg/mL, stock solution, Cat: ab142780, Abcam, UK) were perfused to enable simultaneous membrane voltage (Vm) and intracellular Ca2+ measurements at 37 °C. The detailed dye loading process were: after the contraction were minimized by blebbistatin, 15 μL stock solution of Rhod2-AM and 15 μL pluronic F127 were diluted in 20 mL Krebs solution and circulated in a total circulating volume of 50 ML for 15 mins, then 10 μL stock solution of RH237 was diluted in the 50 mL circulating Krebs solution. Once the dye loading is finished, hearts were electrophysiologically assessed with the optical mapping method, using a custom-designed optical mapping system equipped with an electron multiplying charge-coupled devices (EMCCD) camera (Evolve 512, Photometrics, Tucson, AZ, United States). Hearts were kept in Krebs solution containing 10 μM blebbistatin at 37 °C during imaging. Two 530 nm light emitting diodes (LEDs) were used for excitation of the Ca2+-sensitive dye Rhod-2 AM and voltage-sensitive dye RH237. CaT fluorescence was collected using 585/40 nm bandpass filter while Vm emission was collected using a 662 nm longpass filter. The high-speed EMCCD camera (Evolve 512, Photometrics, Tucson, AZ, United States), giving a high temporal resolution of sub-frames, up to 1000 frames/s, and minimum spatial resolution at the sample of 32 × 32 μm per pixel. The stimulator and ECG recording were simultaneously driven by Spik2 software. For the analysis of optical mapping signals and generation of isochronal maps, data were semi-automatically processed using a modified version of the ElectroMap and OmapScope5 software [20]. Arrhythmia induction protocol Stimuli were generated by an isolated constant voltage/current stimulator (SEN7203, Nihon Kohden, Japan). They were delivered with a platinum electrode onto the epicardial apex at an amplitude 2 × the diastolic voltage threshold and a 2 ms pulse width. The optical mapping was performed in conjunction with an alternans mapping protocol. The heart was consecutively paced at basic cycle lengths (BCL) from 100 ms with progressive 10 ms decrements until a cycle length of 50 ms was reached. The heart was then paced with high frequency, 50 Hz, stimulation. The heart was paced 50 times with 2 ms duration pulses and the optical mapping recording was performed all the time in each episode. This protocol was performed both before and after ISO (1 μM) was delivered. Statistical analysis All data are presented as mean ± standard error the mean, with individual data points superimposed. Differences between group means were examined using two-tailed, paired Student's t-test or using two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons to a P < 0.05 significance level. Results RyR2-R2474S/+ hearts expressed a high pro-arrhythmic tendency We first assessed pro-arrhythmic tendency in WT and RyR2-R2474S/+ mice in vivo (ECG) and ex vivo (ECG, cell membrane voltage (Vm), and Ca2+ transients (CaT)) before and during adrenergic challenge. Isoprenaline (ISO; 10 mg/kg) challenge elicited a high incidence of ventricular arrhythmic events, here illustrated by a biventricular tachycardia (Fig. 1Ai), in RyR2-R2474S/+ but not WT mice in vivo (Fig. 1Aii, P < 0.05, n = 6 for each group) and ex vivo (Fig. 1Bii, P < 0.05, n = 8 for each group). Phase maps demonstrated abnormal re-entrant patterns associated with ventricular arrhythmias in overall cardiac electrical activity in RyR2-R2474S/+ hearts while WT hearts maintained normal conduction. In isolated hearts, typical polymorphic VT was observed in RyR2-R2474S/+ hearts during adrenergic challenge combined with fast pacing protocol (50 Hz). This occurs with multiple activation foci detected by voltage membrane potential mapping as illustrated in Fig. 1C.Fig. 1ECG monitoring and optical mapping recordings in WT and RyR2-R2474S/+ mice. (A) Representative in vivo ECG recordings (i) and incidence of cardiac arrhythmia (ii) in RyR2-R2474S/+ mice before and during ISO challenge (ISO, 10 mg/kg. WT: arrhythmias in 0/6 hearts, RyR2-R2474S/+: arrhythmias in 6/6 hearts). (B) Optical recordings of responses to ISO (1 μM) challenge (i) and incidence of cardiac arrhythmia (ii) in ex vivo WT and RyR2-R2474S/+ hearts (WT: arrhythmias in 0/8 hearts, RyR2-R2474S/+: arrhythmias in 5/8 hearts). (C) Typical optical mapping recording showing pro-arrhythmic re-entry patterns in RyR2-R2474S/+ hearts but not WT hearts.Fig. 1 ECG monitoring and optical mapping recordings in WT and RyR2-R2474S/+ mice. (A) Representative in vivo ECG recordings (i) and incidence of cardiac arrhythmia (ii) in RyR2-R2474S/+ mice before and during ISO challenge (ISO, 10 mg/kg. WT: arrhythmias in 0/6 hearts, RyR2-R2474S/+: arrhythmias in 6/6 hearts). (B) Optical recordings of responses to ISO (1 μM) challenge (i) and incidence of cardiac arrhythmia (ii) in ex vivo WT and RyR2-R2474S/+ hearts (WT: arrhythmias in 0/8 hearts, RyR2-R2474S/+: arrhythmias in 5/8 hearts). (C) Typical optical mapping recording showing pro-arrhythmic re-entry patterns in RyR2-R2474S/+ hearts but not WT hearts. RyR2-R2474S/+ hearts presented abnormal Ca2+ dynamics without accompanied action potential duration and conduction abnormality The proarrhythmic phenotypes were then further investigated employing high-resolution dual-dye optical mapping of Ca2+ homeostasis and ventricular action potential activity in regularly paced WT and RyR2-R2474S/+ Langendorff perfused hearts. For excluding the influence of the results due to spectral overlap or physiological effects between voltage and calcium dyes, we conducted the mapping with single voltage dye or Ca2+ dye only. The results were similar to those obtained with dual dye loading (Supplementary Fig. 1). Fig. 2 illustrates results from assessing the durations of CaT traces following action potential stimulation. The CaT maps illustrate time to x = 50 % and 80 % return to baseline, CaTDx. The typical heatmap of CaTD80 was shown in Fig. 2A. Signals from the whole epicardial surface was averaged to yield overall CaT traces from both WT (blue traces) and RyR2-R2474S/+ ventricles (red traces) before (continuous traces) and during ISO (1 μM) challenge (dotted traces) (Fig. 2B). Dispersions in the measured parameters were measured as the spread between the 5th and 95th percentile of measurements across the heart, divided by the median value. The averaged CaTD50 and CaTD80 data together showed that RyR2-R2474S/+ showed significantly longer CaTD50 than WT both before and during ISO challenge (Fig. 2Ci and Cii). ISO challenge shortened the CaT transients in both experimental groups, but to smaller extents, ΔCaTD, in the RyR2-R2474S/+ than in the WT ventricles (Fig. 2Ei, Eii). Furthermore, the RyR2-R2474S/+ genotype showed reduced CaTD80 dispersion relative to WT and these were unchanged by ISO challenge (Fig. 2D). Systematic analysis of CaTD50 and CaTD80 at apical and basal left and right ventricular (LV and RV) regions of the RyR2-R2474S/+ and WT ventricles corroborated these trends. The local CaT readouts showed a trend towards the longest CaTD in the LV apex compared to all other regions both before and during ISO challenge in both populations. Before ISO challenge, in addition to some RV-LV differences (denoted by *); the region-by-region comparisons demonstrated systematically greater CaTD50 and CaTD80 in RyR2-R2474S/+ relative to WT (denoted by #) (Fig. 3Ai, Bi). ISO challenge accentuated these differences which now extended to both CaTD50 and CaTD80 (Fig. 3Aii and 3Bii). In consequence, ISO challenge produced a reduced shortening of CaT duration ΔCaTD80 in RyR2-R2474S/+ relative to WT. This is reflected in the significance levels observed in the LV apex and base, and RV apex (Fig. 3Ci and Cii). Fig. 3D showed the typical CaTD80 heatmap and sketch map for regional distribution analysis.Fig. 2Calcium transient (CaT) properties of WT and RyR2-R2474S/+ hearts. Typical (A) CaT duration (CaTD) maps at 10 Hz. (B) Averaged optical CaT traces before and during ISO challenge. (C) Averaged CaTD50 (i) and CaTD80 (ii) and (D) CaTD80 dispersion before and during 1 μM ISO challenge. (E) Alterations in CaTD50 (ΔCaTD50, (i)) and CaTD80 (ΔCaTD80, (ii)) induced by 1 μM ISO challenge, in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). (*p < 0.05, **p < 0.01, Baseline vs. 1 μM ISO. ##p < 0.01, ###p < 0.001, WT vs RyR2-R2474S/+ mice). Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons.Fig. 2Fig. 3Regional calcium transient (CaT) properties in WT and RyR2-R2474S/+ hearts. (A) Regional CaTD50 and (B) CaTD80 (means ± SEM) before (i) and during 1 μM ISO challenge (ii) and (C) their resulting alterations, ΔCaTD50 (i) and ΔCaTD80 (ii) (means ± SEM), in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). (D) Typical CaTD80 heatmap and sketch map was shown for regional distribution analysis. LV = left ventricle. RV = right ventricle. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons.Fig. 3 Calcium transient (CaT) properties of WT and RyR2-R2474S/+ hearts. Typical (A) CaT duration (CaTD) maps at 10 Hz. (B) Averaged optical CaT traces before and during ISO challenge. (C) Averaged CaTD50 (i) and CaTD80 (ii) and (D) CaTD80 dispersion before and during 1 μM ISO challenge. (E) Alterations in CaTD50 (ΔCaTD50, (i)) and CaTD80 (ΔCaTD80, (ii)) induced by 1 μM ISO challenge, in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). (*p < 0.05, **p < 0.01, Baseline vs. 1 μM ISO. ##p < 0.01, ###p < 0.001, WT vs RyR2-R2474S/+ mice). Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons. Regional calcium transient (CaT) properties in WT and RyR2-R2474S/+ hearts. (A) Regional CaTD50 and (B) CaTD80 (means ± SEM) before (i) and during 1 μM ISO challenge (ii) and (C) their resulting alterations, ΔCaTD50 (i) and ΔCaTD80 (ii) (means ± SEM), in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). (D) Typical CaTD80 heatmap and sketch map was shown for regional distribution analysis. LV = left ventricle. RV = right ventricle. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons. The parallel electrophysiological Vm measurements revealed ventricular action potential durations (APDx) at either x = 50 % or 80 % full recovery, APD50 and APD80. Their dispersions and action potential propagation readouts were contrastingly either unchanged or altered in directions contrasting with those of the CaT results. Fig. 4 illustrates the related (A) APD80 maps and (B) typical averaged action potential waveforms, and APD50 (Ci) and APD80 values (Cii). These were indistinguishable between RyR2-R2474S/+ and WT hearts before or during ISO challenge. Both RyR2-R2474S/+ and WT showed similar but significantly lower values with ISO challenge (C, E). The APD80 dispersions remained indistinguishable through both cardiac genotypes and pharmacological conditions. In addition, we further investigated the restitution curves with S1S1 pacing and ERP with S1S2 pacing. The data shown in Fig. 4F and G demonstrated that there was no significant difference about the restitution curves and ERP between RyR2-R2474S/+ and WT heart with or without ISO challenge.Fig. 4Action potential properties of WT and RyR2-R2474S/+ hearts. Typical maps of action potential duration at 80 % recovery (APD80) (A) and averaged optical action potential traces (B). (C) Averaged APD50 (i) and APD80 (ii) and (D) averaged APD80 dispersion before and during 1 μM ISO challenge. (E) Alterations in APD50 (ΔAPD50, (i)) and APD80 (ΔAPD80, (ii)) induced by 1 μM ISO in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). (F) Restitution curves and ERP (G) between RyR2-R2474S/+ and WT heart with or without challenge of ISO (F) (n = 5 for WT, n = 5 for RyR2-R2474S/+ group). *p < 0.05, **p < 0.01. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons.Fig. 4Fig. 5Regional action potential properties of WT and RyR2-R2474S/+ hearts. (A) Regional APD50 and (B) APD80 values before (i) and during 1 μM ISO challenge (ii) and (C) the resulting ΔAPD50, (i) and ΔAPD80 (ii) in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). LV = left ventricle. RV = right ventricle. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons.Fig. 5 Action potential properties of WT and RyR2-R2474S/+ hearts. Typical maps of action potential duration at 80 % recovery (APD80) (A) and averaged optical action potential traces (B). (C) Averaged APD50 (i) and APD80 (ii) and (D) averaged APD80 dispersion before and during 1 μM ISO challenge. (E) Alterations in APD50 (ΔAPD50, (i)) and APD80 (ΔAPD80, (ii)) induced by 1 μM ISO in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). (F) Restitution curves and ERP (G) between RyR2-R2474S/+ and WT heart with or without challenge of ISO (F) (n = 5 for WT, n = 5 for RyR2-R2474S/+ group). *p < 0.05, **p < 0.01. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons. Regional action potential properties of WT and RyR2-R2474S/+ hearts. (A) Regional APD50 and (B) APD80 values before (i) and during 1 μM ISO challenge (ii) and (C) the resulting ΔAPD50, (i) and ΔAPD80 (ii) in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). LV = left ventricle. RV = right ventricle. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons. Systematic analyses of APD50 and APD80 through the different apical and basal, LV and RV, regions in WT and RyR2-R2474S/+ hearts before and during ISO challenge confirmed this overall trend. Here, the LV apex showed the longest APD50 and APD80 amongst ventricular regions whether before or during the ISO challenge (Fig. 5A and B). There did exist significant apex-base, LV-RV, APD50 and APD80, differences within each WT or RyR2-R2474S/+ group both before and during the ISO challenge. However, there were no differences in these readouts between corresponding recording sites in the WT or RyR2-R2474S/+, whether before or during the ISO challenge in any given region. Thus, ISO challenge produced similar shortenings, ΔAPD50 and ΔAPD80, through all regions in both WT and RyR2-R2474S/+ (Fig. 5C). There was no difference in dispersion in the APD80 readings between groups or conditions. Measurements of ventricular conduction velocity (Supplementary Fig. 1) demonstrated similar velocities in both WT and RyR2-R2474S/+ hearts under both baseline and ISO challenge conditions (Supplementary Fig. 1A and B), with dispersions indistinguishable between these (Supplementary Fig. 1C). RyR2-R2474S/+ hearts present abnormal temporal relationships between the CaT and Vm The final analyses compared temporal relationships between the CaT and Vm signal waveforms obtained under the different conditions in the experimental groups. The Vm-CaT latencies were quantified by the time intervals between their respective rising time to half peak, their time to peak and their time to half decay. Results from RyR2-R2474S/+ and WT hearts before and following ISO challenge were compared. Fig. 6A and B exemplifies the latencies for the upstroke and decay phases under these conditions. Fig. 6C illustrates the corresponding averaged and superimposed CaT and Vm traces. These demonstrated similar Vm-CaT latency involving rising time to half peak time, and divergent Vm-CaT latency in their time to peak in RyR2-R2474S/+ compared to WT (Fig. 6Di, Dii) RyR2-R2474S/+ hearts demonstrated a significantly prolonged latency time between peak transmembrane voltage and peak cytosolic Ca2+, and time to 50 % voltage repolarization and decay in cytosolic Ca2+ (Fig. 6Diii). As shown in Fig. 6E, after ISO intervention under S1S1 programmed pacing, RyR2-R2474S/+ hearts exhibited frequency-dependent CaT alternans and corresponding APD alternans but not WT hearts. Such CaT and APD alternans occurred mostly semiannually in specific region of the ventricular pre occurrence of VT. Interestingly, following 50 Hz burst pacing in a RyR2-R2474S/+ heart, ventricular localized spatial discordant CaT alternans were observed and then quickly converted into spatial concordant alternans (Fig. 6F). Moreover, though phase analysis, we found that CaT oscillation manifested as rotating waves (Fig. 6G). Fig. 7 illustrated systematic statistical results of regional analysis of voltage‑calcium latencies. Fig. 7Ai showed that no difference of midpoint latencies in all region of WT and RyR2-R2474S/+ hearts, while ISO intervention broke their regional balance (Fig. 7Aii). RV peak latencies in RyR2-R2474S/+ hearts were prolonged compared with WT hearts (Fig. 7B). Increased decay latencies were observed in RyR2-R2474S/+ relative to WT hearts during ISO challenge (Fig. 7C). Fig. 7D showed no difference was found in the Δ value of latency alteration in both groups. The scheme diagram of latencies was illustrated in Fig. 7E.Fig. 6Comparisons of CaT and Vm findings in WT and RyR2-R2474S/+ hearts and CaT abnormalities during ISO challenge in RyR2-R2474S/+ hearts. Typical voltage‑calcium latency mapping of (A) half rise time and (B) time to 50 % full recovery and averaged dual voltage‑calcium signals. (C) Averaged time lags between their half rise time, (i), time to peak (ii) and time to half recovery (iii) before and during 1 μM ISO challenge in WT (n = 4) and RyR2-R2474S/+ hearts (n = 4). (D) frequency-dependent CaT alternans was observed in RyR2-R2474S/+ hearts after ISO challenge, not in WT mice. Changeable CaT alternans manifested as SDA and SCA (E) and phase maps showing reentrant activity (F) under 50 Hz burst pacing after ISO challenge in RyR2-R2474S/+ hearts. #p < 0.05, ##p < 0.01 WT vs. RyR2-R2474S/+ mice. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons.Fig. 6Fig. 7Regional voltage-calcium properties in WT and RyR2-R2474S/+ hearts. Regional latencies between (A) half rise time, (B) time to peak and (C) time to half recovery before (i) and following 1 μM ISO challenge (ii), and (D) the resulting changes in latencies between half rise time (i), time to peak (ii) and time to half recovery (iii), in WT (n = 4) and RyR2-R2474S/+ mice (n = 4). (E) Schematic diagram of voltage‑calcium latency. LV = left ventricle. RV = right ventricle. *p < 0.05, **p < 0.01, ***p < 0.001. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons.Fig. 7 Comparisons of CaT and Vm findings in WT and RyR2-R2474S/+ hearts and CaT abnormalities during ISO challenge in RyR2-R2474S/+ hearts. Typical voltage‑calcium latency mapping of (A) half rise time and (B) time to 50 % full recovery and averaged dual voltage‑calcium signals. (C) Averaged time lags between their half rise time, (i), time to peak (ii) and time to half recovery (iii) before and during 1 μM ISO challenge in WT (n = 4) and RyR2-R2474S/+ hearts (n = 4). (D) frequency-dependent CaT alternans was observed in RyR2-R2474S/+ hearts after ISO challenge, not in WT mice. Changeable CaT alternans manifested as SDA and SCA (E) and phase maps showing reentrant activity (F) under 50 Hz burst pacing after ISO challenge in RyR2-R2474S/+ hearts. #p < 0.05, ##p < 0.01 WT vs. RyR2-R2474S/+ mice. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons. Regional voltage-calcium properties in WT and RyR2-R2474S/+ hearts. Regional latencies between (A) half rise time, (B) time to peak and (C) time to half recovery before (i) and following 1 μM ISO challenge (ii), and (D) the resulting changes in latencies between half rise time (i), time to peak (ii) and time to half recovery (iii), in WT (n = 4) and RyR2-R2474S/+ mice (n = 4). (E) Schematic diagram of voltage‑calcium latency. LV = left ventricle. RV = right ventricle. *p < 0.05, **p < 0.01, ***p < 0.001. Two-way Analysis of Variance (ANOVA) with Sidak's test for multiple comparisons. Discussion Of genetic abnormalities implicated in CPVT, those involving RYR have the commonest clinical incidence. The RYR mutations associated with CPVT cluster in 3 disease-susceptible regions of the channel [21]. Those in the central RYR2 region include the RyR2-R2474S missense mutation first reported in identical twin brothers presenting with syncope and exercise-induced ventricular tachycardia (VT) [6]. Subsequent studies associated RYR2-R2474S with increased sensitivity to PKA resulting in increased open probabilities and gating frequencies [7]. This increased sensitivity to Ca2+-induced activation occurred even at moderate [Ca2+]i. Heterozygous, RyR2-R2474S/+, mice exhibited exercise-induced ventricular arrhythmias and sudden cardiac death recapitulating clinical CPVT [19]. They also showed spontaneous generalized tonic-clonic seizures that could occur in the absence of cardiac arrhythmias. Treatment with the RyR2-specific agent S107 that enhances calstabin2 binding to RyR2-R2474S channel inhibited the channel leak, prevented the cardiac arrhythmias, and raised the seizure threshold. Interestingly, two studies recently reported that long-term exercise training reduced the arrhythmic propensity while restoring normal Ca2+ handling in RyR2-R2474S mice [22,23]. However, to date, to the best of our knowledge, there are no reports clarifying the relationship between transmembrane potential changes (Vm) accompanying the action potential and intracellular Ca2+ transients (CaT) during excitation in intact murine RyR2-R2474S hearts. The present characterization first demonstrated an increased arrhythmogenic tendency together with abnormal Ca2+ transients in RyR2-R2474S/+ hearts particularly during the ISO challenge. Phase maps showed accompanying abnormal re-entry patterns associated with ventricular arrhythmias. Our murine RyR2-R2474S platform thus recapitulated the exercise-induced ventricular tachycardia phenotypes previously reported in such patients [6]. Detailed ventricular epicardial mapping then determined both overall averaged CaT characteristics and localized readouts from individual corresponding apical and basal LV and RV epicardial regions. The LV apex demonstrated the greatest CaT durations (CaTD). However, all recording sites in unchallenged RyR2-R2474S/+ showed longer CaTD than the corresponding regions in WT hearts. ISO (1 μM) challenge then shortened the CaTD but accentuated the differences between genotypic groups. The latter suggests that ISO reduced CaTD less effectively in RyR2-R2474S/+ than WT. Vm mapping similarly showed the longest APD50 and APD80 in the LV apical regions, and apex-base and LV-RV differences within both RyR2-R2474S/+ and WT groups both before and during ISO stress. However, unchallenged RyR2-R2474S/+ and WT showed similar APD50 and APD80. ISO challenge then shortened both APD50 and APD80 but with similar effectiveness in RyR2-R2474S/+ and WT which continued to show similar APD50 and APD80. RyR2-R2474S/+ and WT, whether before or during ISO challenge, showed similar action potential conduction velocities. These contrasting CaT and Vm changes are compatible with altered excitation contraction coupling processes distinct from any accompanying membrane excitation changes. The differences were quantified by deriving and comparing differences between the corresponding CaT and Vm traces. We systematically determined Vm-CaT latency between their rising time to half peak, time to peak and time to half recovery between the different ventricular epicardial regions. Differences in such Vm-CaT latency between RyR2-R2474S/+ and WT hearts before and during ISO challenge occurred for the time to half recovery. Such findings thus selectively implicate a delayed inactivation in CaT relative to action potential recovery in the pro-arrhythmic action of RyR2-R2474S/+ in intact hearts. Ca2+ or/and APD alternans were the risk factor for life threatening cardiac arrhythmias and the important underlying mechanism of occurrence of cardiac arrhythmia [24]. APD alternans lead to larger wavelength oscillations and heterogeneity, which may contribute to electrical instability, isotopic beat and reentry, which accelerated the occurrence of ventricular arrhythmias [25]. APD alternans occurred with or without CaT alternans. In this study, abnormal Ca2+ transients were the original initiator of CPVT in RyR2-R2474S/+ mice. Therefore, APD alternans always occurred with CaT alternans. It was interesting that CaT alternans showed obvious heterogeneity (Fig. 6E). The localized CaT alternans may be the important original trigger of CPVT in RyR2-R2474S/+. In conclusion, our mapping study of the transmembrane potential (Vm) and intracellular Ca2+ transient (CaT) in intact hearts of RyR2-R2474S mice, in particular the analysis of voltage-calcium latency, provide new insights into the arrhythmogenic mechanisms of CPVT at tissue level. The following is the supplementary data related to this article.Supplementary Fig. 1Action potential conduction properties in WT and RyR2-R2474S/+ hearts. (A) Typical isochronal maps. (B) Averaged conduction velocities and (C) conduction velocity dispersion before and following 1 μM ISO challenge in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). Panels D to I are based on voltage dye-only (RH237) optical mapping at baseline. (D) typical APD80 and APD50 maps of WT and RyR2-R2474S/+ hearts. (E) Statistical results of APD50 (i) and its dispersion (ii). (F) Statistical results of APD80 (i) and its dispersion (ii). Isochronal maps (G), activation curves (H) and CV statistical results (I) of WT and RyR2-R2474S/+ hearts. (n = 5 for each group).Supplementary Fig. 1 Action potential conduction properties in WT and RyR2-R2474S/+ hearts. (A) Typical isochronal maps. (B) Averaged conduction velocities and (C) conduction velocity dispersion before and following 1 μM ISO challenge in WT (n = 5) and RyR2-R2474S/+ hearts (n = 5). Panels D to I are based on voltage dye-only (RH237) optical mapping at baseline. (D) typical APD80 and APD50 maps of WT and RyR2-R2474S/+ hearts. (E) Statistical results of APD50 (i) and its dispersion (ii). (F) Statistical results of APD80 (i) and its dispersion (ii). Isochronal maps (G), activation curves (H) and CV statistical results (I) of WT and RyR2-R2474S/+ hearts. (n = 5 for each group). CRediT authorship contribution statement Yangpeng Li: Writing – original draft, Investigation, Formal analysis, Data curation. Zhu Liu: Methodology, Formal analysis, Data curation. Christopher O'Shea: Writing – review & editing, Software, Methodology. Jianhong Li: Software, Methodology, Investigation, Data curation. Xian Luo: Formal analysis, Data curation. Tangting Chen: Writing – review & editing, Formal analysis, Data curation. Xianhong Ou: Software, Data curation. Weichao Liu: Software, Formal analysis. Guoliang Hao: Software. Christopher L.-H. Huang: Writing – review & editing. Davor Pavlovic: Writing – review & editing. Xiaoqiu Tan: Writing – original draft, Supervision, Funding acquisition, Conceptualization. Ming Lei: Supervision, Conceptualization. Funding This research was funded by the 10.13039/501100001809National Natural Science Foundation of China [No. 82270334 (XT), 81670310 (XT), No. 81700308 (XO) and No. 31871181 (ML)], 10.13039/501100004829Science and Technology Department of Sichuan Province, China [No. 2022YFS0635 (YL), No. 2024JDHJ0051 (XT), No. 2022YF0607 (XT)] and the 10.13039/501100000274British Heart Foundation, UK [PG/14/80/31106 (ML), PG/16/67/32340 (ML), PG/19/59/34582 (CLHH), PG/14/79/31102 (CLHH)]. COS: 10.13039/100010269Wellcome (221650/Z/20/Z), BHF (AA/18/2/34218), 10.13039/501100000266EPSRC (L016346). DP: Wellcome (109604/Z/15/Z), BHF (PG/17/55/33087, RG/17/15/33106, FS/19/12/34204, FS/19/16/34169), EPSRC (L016346). Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.